GlaxoSmithKline Plc sued U.S. regulators to block the sale of a generic form of the company's Flonase allergy drug, saying the copy may not work the same.
The lawsuit, filed today in U.S. District Court in Baltimore, said the Food and Drug Administration failed to establish that the generic copy of Flonase worked the same way as the original nasal spray. The FDA yesterday approved Boehringer Ingelheim GmbH's application to sell the generic version.
Just stop it GlaxoSmithKline! This kind of activity gives your industry a bad name and politicians the ammunition they need to bring you down. You've had your 20 years of patent monopoly on Flonase. That was the deal you agreed to when you got the patent. Stick to it and go create some new cures; then make all the money you can off your new patents.